510(k) · Cleared
ClearedCalcigen -Nap Bone Void Filler
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly
Biomet, Inc. · MQV Filler, Bone Void, Calcium Compound
Cleared on Apr 27, 2004 as substantially equivalent to K011386 (Ebi, L.P., 2001) and 5 other predicates after a 162-day review. Its family tree reaches back 2 generations to 1996.
- Decided
- Apr 27, 2004
- Review
- 162 days
- Class
- Class II
- Product code
- MQV
- Recalls
- None
- Predicates
- 6
Its longest line of descent runs back 2 generations to K960978 (1996). 8 ancestors in all. No later device cites it as a predicate yet.
View FIG. 1 as a table
Line of descent and top descendants
| Generation | Number | Device | Applicant | Decided | Recalls |
|---|---|---|---|---|---|
| −2 | K960978 | Wright Plaster of Paris Pellets (Subject to Revision) | Wrightmedicaltechnologyinc | 1996 | — |
| −1 | K980817 | Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05… | Interpore Intl. | 1998 | — |
| 0 (this device) | K033611 | Calcigen -Nap Bone Void Filler | Biomet, Inc. | 2004 | — |
Other ancestors by year cleared
| Year cleared | Devices | With a Class I recall |
|---|---|---|
| 1997 | 1 | 0 |
| 1999 | 1 | 0 |
| 2001 | 4 | 0 |
Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.
Planning a device in MQV? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.
Top candidate predicates for a new MQV device
- #1 K232315 Catalyst Bone Void Fillerscore 25.2 · 25 generations · no Class I recall
- #2 Held for the reportin the report
- #3 Held for the reportin the report
What was it cleared against? (6)
Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.
| Type | Number | Device | Decided |
|---|---|---|---|
| * | K011386 | Ebi Osteostim Granules-Resorbable Bone Graft SubstituteSummary page 1…(21 CFR 888.3045) Legally Marketed Devices To Which Substantial Equivalence Is Claimed: * EBI OsteoStim TM Granules - Resorbable Bone Graft Substitute (EBI L.P.; K01 1386) * a-BSM® Bone Substitute Material (DePuy Orthopaedics, Inc; K01 1048) * Pro Osteon® 50OR Resorbable Bone Graft Substitute (Inter… | 2001 |
| * | K011048 | BSM Bone Substitute MaterialSummary page 1…Equivalence Is Claimed: * EBI OsteoStim TM Granules - Resorbable Bone Graft Substitute (EBI L.P.; K01 1386) * a-BSM® Bone Substitute Material (DePuy Orthopaedics, Inc; K01 1048) * Pro Osteon® 50OR Resorbable Bone Graft Substitute (Interpore Cross; K990131, K980817) * Norian® SRS® Bone Void Filler (Synth… | 2001 |
| * | K990131 | Pro Osteon Implant 500R Resorbable Bone Graft SubstituteSummary page 1…tute (EBI L.P.; K01 1386) * a-BSM® Bone Substitute Material (DePuy Orthopaedics, Inc; K01 1048) * Pro Osteon® 50OR Resorbable Bone Graft Substitute (Interpore Cross; K990131, K980817) * Norian® SRS® Bone Void Filler (Synthes USA; K01 1897) • 3i® Calcium Sodium Phosphate Bone Cement (Biomet, Inc; K00349… | 1999 |
| * | K980817 | Pro Osteon Implant 500R Resorbable Bone Graft Substitute Model Numbers 5RG05, 5RG10…Summary page 1…L.P.; K01 1386) * a-BSM® Bone Substitute Material (DePuy Orthopaedics, Inc; K01 1048) * Pro Osteon® 50OR Resorbable Bone Graft Substitute (Interpore Cross; K990131, K980817) * Norian® SRS® Bone Void Filler (Synthes USA; K01 1897) • 3i® Calcium Sodium Phosphate Bone Cement (Biomet, Inc; K003493) Devic… | 1998 |
| * | K011897 | Norian SRS Bone Void FillerSummary page 1…ePuy Orthopaedics, Inc; K01 1048) * Pro Osteon® 50OR Resorbable Bone Graft Substitute (Interpore Cross; K990131, K980817) * Norian® SRS® Bone Void Filler (Synthes USA; K01 1897) • 3i® Calcium Sodium Phosphate Bone Cement (Biomet, Inc; K003493) Device Description: CalcigenT M-NaP Bone Void Filler is a syn… | 2001 |
| * | K003493 | 3I Calcium Sodium Phosphate Bone CementSummary page 1…e Graft Substitute (Interpore Cross; K990131, K980817) * Norian® SRS® Bone Void Filler (Synthes USA; K01 1897) • 3i® Calcium Sodium Phosphate Bone Cement (Biomet, Inc; K003493) Device Description: CalcigenT M-NaP Bone Void Filler is a synthetic, self-setting paste for use as a bone graft substitute. The… | 2001 |
What descends from it?
No later submission names this one as a predicate yet.
Has anything in its family been recalled? (0 Class I)
No FDA recall names this device.
No ancestor or descendant has a Class I recall.
What does this lineage say?
- The line of descent spans 8 years and passes through 3 companies; a new generation was cleared every 5.6 years on median.
- None of the 8 ancestors has a recall.
- 1 other device also cites its predicate K011386.
How does its category compare?
All MQV devicesMQV Filler, Bone Void, Calcium Compound: FDA decisions, review times, recalls and adverse event reports over 20 years.
FDA decisions per year · MQV
14in 2025
2026 to Oct 25, outlined.
Median 510(k) review, days · MQV
57in 2025
Receipt to decision; years with fewer than 3 clearances left blank.
Recalls per year · MQV
1in 2025
Class I (0 since 2007) Class II/III not classified
Adverse event reports per year · MQV
57in 2025
MAUDE reports naming product code MQV, not matched to any one device; reports are not rates.
View these four charts as a table
| Year | Decisions | Median 510(k) review, days | Recalls (Class I) | MAUDE reports |
|---|---|---|---|---|
| 2007 | 35 | 144 | 5 | 67 |
| 2008 | 32 | 102 | 3 | 71 |
| 2009 | 23 | 180 | 1 | 81 |
| 2010 | 17 | 147 | 0 | 68 |
| 2011 | 16 | 92 | 6 | 114 |
| 2012 | 9 | 107 | 3 | 149 |
| 2013 | 12 | 197 | 2 | 223 |
| 2014 | 20 | 153 | 0 | 111 |
| 2015 | 18 | 184 | 0 | 125 |
| 2016 | 8 | 214 | 1 | 106 |
| 2017 | 17 | 124 | 1 | 107 |
| 2018 | 23 | 124 | 2 | 86 |
| 2019 | 13 | 90 | 0 | 65 |
| 2020 | 15 | 132 | 1 | 126 |
| 2021 | 8 | 88 | 0 | 101 |
| 2022 | 9 | 118 | 0 | 47 |
| 2023 | 21 | 74 | 3 | 120 |
| 2024 | 28 | 55 | 2 | 68 |
| 2025 | 14 | 57 | 1 | 57 |
| 2026 | 5 | 96 | 4 | — |
What is it indicated for?
Calcigen T '-NaP Bone Void Filler is intended for filling bony voids of the skeletal system (i.e., the extremities, spine and pelvis). These defects may be surgically created osseous defects or osseous defects created from disease or traumatic injury to the bone. The device is intended for bone voids or gaps that are not intrinsic to the structural integrity of the bony structure.
Indications for use as stated in the FDA summary.
https://510kreport.com/device/K033611 · printed Nov 6, 2026
Cite this page
510(k) Report. “K033611: Calcigen -Nap Bone Void Filler.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K033611
Report an extraction error
Are you the manufacturer?
Record history
- FDA decision record loaded May 2, 2026
- Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
- Lineage and recalls computed Nov 3, 2026
- Page last updated Nov 3, 2026